Shire PLC (SHPG.OQ)
14 Dec 2017
* SHIRE PLC SAYS NEW FORMULATION OF ONCASPAR RECEIVES MARKETING AUTHORIZATION IN EUROPE FOR PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
* SHIRE PLC SAYS JOHN MILLER TO SERVE AS INTERIM CFO WITH EFFECT FROM JAN 1, 2018 UNTIL THOMAS DITTRICH COMMENCES HIS EMPLOYMENT WITH CO - SEC FILING
LONDON Whitbread shares jumped more than 7 percent on Wednesday after U.S.-based hedge fund Sachem Head Capital Management declared a 3.4 percent stake in the British hotel and coffee chain operator.
Shire Plc said on Tuesday it had partnered with a California-based company to develop a new way to administer a drug to treat hemophilia A.
Dec 5 Shire Plc said on Tuesday it had partnered with a California-based company to develop a new way to administer a drug to treat hemophilia A.
BRIEF-Shire And Rani Therapeutics enter into collaboration to evaluate use of the Rani Pill technology
* SHIRE AND RANI THERAPEUTICS ENTER INTO COLLABORATION TO EVALUATE USE OF THE RANI PILL(TM) TECHNOLOGY FOR THE ORAL DELIVERY OF FACTOR THERAPY
* Mediclinic, Spire shares fall after takeover talks fall through
* Shares in rival Shire climb 6 pct (Adds projected price of drug, company comment)
* Omega Advisors Inc dissolves share stake in Carrizo Oil & Gas Inc - SEC Filing
* Third Point LLC dissolves Class A share stake in Charter Communications Inc - SEC filing
|Novartis AG (NOVN.S)||CHF83.50||-0.35|
|Eli Lilly and Co (LLY.N)||$86.50||-1.39|
|Catalyst Biosciences Inc (CBIO.OQ)||$9.93||--|
|Abbott Laboratories (ABT.N)||$54.73||-0.33|
|Actelion Ltd (ATLN.S)||--||--|
|Supernus Pharmaceuticals Inc (SUPN.OQ)||$38.60||--|
|Salix Pharmaceuticals, Ltd. (SLXP.OQ)||--||--|
|ARYx Therapeutics, Inc. (ARYX.PK)||$0.00||0.00|
|Innoviva Inc (INVA.OQ)||$13.28||--|
|Sucampo Pharmaceuticals, Inc. (SCMP.OQ)||$16.75||+0.25|